Medicover AB (publ)

OM:MCOV B Rapport sur les actions

Capitalisation boursière : SEK 26.2b

Medicover Gestion

Gestion contrôle des critères 3/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Fredrik Rågmark

Directeur général

€2.7m

Rémunération totale

Pourcentage du salaire du PDG39.2%
Durée du mandat du directeur général27.8yrs
Propriété du PDG1.0%
Durée moyenne d'occupation des postes de direction3.4yrs
Durée moyenne du mandat des membres du conseil d'administration15.3yrs

Mises à jour récentes de la gestion

Recent updates

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Nov 07
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Oct 24
Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Apr 22
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Mar 05
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Feb 11
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Dec 20
Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Dec 02
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Sep 12
Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Aug 21
Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Jun 12
Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

May 27
Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

Is Medicover (STO:MCOV B) Using Too Much Debt?

May 12
Is Medicover (STO:MCOV B) Using Too Much Debt?

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Feb 16
Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Is Medicover (STO:MCOV B) Using Too Much Debt?

Jan 30
Is Medicover (STO:MCOV B) Using Too Much Debt?

Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Dec 30
Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Dec 17
Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Oct 30
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Oct 16
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Sep 09
Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Jul 25
Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Jul 12
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

Jun 13
Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?

May 29
At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?

Analyse de la rémunération des PDG

Comment la rémunération de Fredrik Rågmark a-t-elle évolué par rapport aux bénéfices de Medicover?
DateRémunération totaleSalaireBénéfices de l'entreprise
Sep 30 2024n/an/a

€20m

Jun 30 2024n/an/a

€23m

Mar 31 2024n/an/a

€22m

Dec 31 2023€3m€1m

€18m

Sep 30 2023n/an/a

€8m

Jun 30 2023n/an/a

€5m

Mar 31 2023n/an/a

€1m

Dec 31 2022€3m€1m

€12m

Sep 30 2022n/an/a

€37m

Jun 30 2022n/an/a

€59m

Mar 31 2022n/an/a

€88m

Dec 31 2021€2m€952k

€102m

Sep 30 2021n/an/a

€93m

Jun 30 2021n/an/a

€90m

Mar 31 2021n/an/a

€52m

Dec 31 2020€2m€670k

€26m

Sep 30 2020n/an/a

€14m

Jun 30 2020n/an/a

€4m

Mar 31 2020n/an/a

€16m

Dec 31 2019€1m€900k

€23m

Sep 30 2019n/an/a

€19m

Jun 30 2019n/an/a

€19m

Mar 31 2019n/an/a

€20m

Dec 31 2018€1m€807k

€22m

Sep 30 2018n/an/a

€28m

Jun 30 2018n/an/a

€26m

Mar 31 2018n/an/a

€23m

Dec 31 2017€921k€810k

€19m

Rémunération vs marché: La rémunération totale de Fredrik ($USD 2.85M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Swedish ($USD 906.72K ).

Rémunération et revenus: La rémunération de Fredrik a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Fredrik Rågmark (61 yo)

27.8yrs

Titularisation

€2,707,000

Compensation

Mr. Fredrik Ragmark serves as the Chief Executive Officer of Medicover AB (publ). Mr. Ragmark has been employed with Medicover since 1996. He serves as Managing Director and Board Member of Kalvskär AB.Fr...

Équipe de direction

NomPositionTitularisationCompensationPropriété
Fredrik Rågmark
CEO & Directorno data€2.71m1.04%
SEK 272.5m
Anand Patel
Chief Financial Officerless than a yearpas de donnéespas de données
Jaroslaw Urbanczyk
Chief Information Officer5.1yrspas de données0.0052%
SEK 1.3m
Hanna Bjellquist
Head of Investor Relationsno datapas de donnéespas de données
Jenny Brandt
General Legal Counselno datapas de données0.031%
SEK 8.1m
Andrew Vallance-Owen
Chief Marketing Officerno datapas de donnéespas de données
Kamila Skorupinski
Group Chief People Officerless than a yearpas de donnéespas de données
John Stubbington
Chief Operating Officer of Healthcare Services8.8yrspas de données0.53%
SEK 138.4m
Staffan Ternstrom
Chief Operating Officer for Diagnostic Services3.4yrspas de données0.035%
SEK 9.2m

3.4yrs

Durée moyenne de l'emploi

57.5yo

Âge moyen

Gestion expérimentée: L'équipe de direction de MCOV B est considérée comme expérimentée (ancienneté moyenne 3.4 ans).

Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Fredrik Rågmark
CEO & Director27.8yrs€2.71m1.04%
SEK 272.5m
Robert Jochnick
Independent Director17.8yrs€54.60k1.21%
SEK 317.0m
Fredrik Stenmo
Independent Chairman19.8yrs€101.50k4.41%
SEK 1.2b
Margareta Nordenvall
Independent Director23.8yrs€66.20k0.060%
SEK 15.7m
Arno Bohn
Independent Director23.8yrs€63.05k0.20%
SEK 52.3m
Cecil Michael Flemming
Independent Director9.8yrs€78.30kpas de données
Anne Berner
Independent Director2.6yrs€59.85kpas de données
Azita Shariati
Independent Director2.6yrs€63.05k0.0015%
SEK 384.5k
Peder Jochnick
Independent Director12.8yrs€54.60k2.59%
SEK 676.7m
Sonali Chandmal
Independent Director7.8yrs€71.45k0.017%
SEK 4.4m

15.3yrs

Durée moyenne de l'emploi

60.5yo

Âge moyen

Conseil d'administration expérimenté: Le conseil d'administration de la MCOV B est chevronné et expérimenté ( 15.3 années d'ancienneté moyenne).